XML 149 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]    
Net loss $ (20,840) $ (54,225)
Other comprehensive income (loss):    
Available for sale securities - net unrealized gain 12 52
Cumulative translation adjustment arising during the period (25) (11)
Total other comprehensive income (loss) (13) 41
Comprehensive loss (20,853) (54,184)
Comprehensive income (loss) attributable to noncontrolling interests 0 0
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (20,853) $ (54,184)